Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
Electronic copy available at: http://ssrn.com/abstract=1217442
1110
The Business Lawyer; Vol. 63, August 2008
issuance of some of the outstanding stock. Examples of such omissions and de-fects are limitless, but not infrequently found examples include the absence of board resolutions authorizing the issuance of stock shown by the transfer booksto have been issued, the absence of evidence that issuances were properly autho-rized by the requisite votes of the board or, if required, by the stockholders, theabsence of evidence that the consideration due to the corporation in exchangefor the stock was in fact received, the issuance of more shares than were autho-rized by the certificate of incorporation at the time, the issuance of stock priorto the filing of the charter amendment or certificate of designations authorizingor creating the stock, and similar procedural and substantive irregularities. Notinfrequently, these defects occurred some time ago, and the stock in question mayhave changed hands multiple times since issuance.Confronted with such irregularities, most corporate lawyers’ first instinct wouldlikely be to attempt to correct the defect through board and, if necessary, stock-holder ratification of the defective issuance, with the intent of putting the par-ties in the positions they thought they were in prior to discovering the irregularity.However, Delaware courts have not always viewed defects in stock issuances asbeing curable by ratification. In a number of leading cases, the Delaware SupremeCourt has treated the statutory formalities for the issuance of stock as substantiveprerequisites to the validity of the stock being issued, and the court has deter-mined that failure to comply with such formalities renders the stock in ques-tion void.
3
A finding that stock is void means that defects in it cannot be cured,whether by ratification or otherwise.
4
Thus, practitioners finding defects in stockissuances are put in the uncomfortable position of having to make a judgmentwhether the defect is one that renders the stock void, in which case ratification isnot an option, or voidable, in which case ratification is an option. Unfortunately,the decisions issued by the Delaware courts have not afforded certainty in thiscritical area. Indeed, the Court of Chancery acknowledged in a recent decisionthat although “Delaware law is replete with cases” discussing the void-voidabledistinction, the law as to when and whether a defective stock issuance is curable“is not as clear as it could be.”
5
This Article analyzes the reasons for this lack of clarity and proposes some solu-tions that would benefit buyers and sellers of corporate stock. We begin by exam-ining the legal requirements applicable to stock issuances. Next, we discuss thefoundation of the doctrinal distinction between void and voidable stock. We thendiscuss the cases where courts have found stock to have
not
been issued in ac-cordance with the legal requirements applicable to stock issuances, and whethersuch finding has resulted in the stock being found void or voidable. We also con-sider the purposes, principles, and policies of certain provisions of Article 8 of the
3.
See, e.g
.,
infra
notes 114–36 and accompanying text (discussing
Staar Surgical Co. v. Waggoner,supra
note 1).4.
See, e.g
.,
infra
note 75 and accompanying text (quoting holding of
Triplex Shoe Co. v. Rice &Hutchins, Inc
., 152 A. 342, 347– 48 (Del. 1930)).5.
MBKS
, 924 A.2d at 973.
02_Bigler.indd 1110
02_Bigler.indd 1110
8/21/2008 9:23:54 PM
8/21/2008 9:23:54 PM